Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma
- PMID: 8397370
Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma
Abstract
The primary tumors from 15 untreated patients with Burkitt's lymphoma were analysed for abnormalities in the coding region of the MYC gene by single stranded conformational polymorphism (SSCP) analysis followed by DNA sequencing. Fourteen of the 15 tumors had one or more clonal mutations. Forty one mutations were found in the second exon; only one occurred in the third exon. Seven tumors had mutations that clustered in a region spanning amino acids 38-63. Four of these possessed mutations that altered prolines at positions 57 (3), 60 (1), and 63 (1). Seven tumors were mutated in the central portions of the second exon. These occurred at position 95 (2), position 115 (2), position 137 (1), and position 138 (3). Analysis of the published sequences from five lymphoma cell lines and one primary tumor showed a similar clustering of mutations, with all six having mutations in codons between positions 38-63. The regions where mutations occurred have been associated with a variety of properties, including transcriptional activation and cellular transformation. The number and location of mutations showed no correlation with either chromosome 8 or chromosome 14 breakpoints or with the Epstein-Barr virus positivity of the tumors. This unexpected, frequent occurrence of clustered mutations in the second exon of the MYC gene suggests a role for the mutated MYC proteins in the pathogenesis of Burkitt's lymphoma, possibly through altered interactions of this domain with other cellular factors.
Similar articles
-
Epstein-Barr virus and Burkitt's lymphoma.Semin Cancer Biol. 1992 Oct;3(5):285-95. Semin Cancer Biol. 1992. PMID: 1335792
-
Level of MYC overexpression in pediatric Burkitt's lymphoma is strongly dependent on genomic breakpoint location within the MYC locus.Genes Chromosomes Cancer. 2004 Oct;41(2):178-82. doi: 10.1002/gcc.20063. Genes Chromosomes Cancer. 2004. PMID: 15287031
-
[Epstein-Barr virus and Burkitt's lymphoma].Med Trop (Mars). 1999;59(4 Pt 2):499-502. Med Trop (Mars). 1999. PMID: 10901854 French.
-
The etiology of Burkitt's lymphoma and the history of the shaken dogmas.Blood Cells. 1993;19(3):667-73; discussion 674-5. Blood Cells. 1993. PMID: 8018947 Review.
-
[Possible mechanisms of activation of the cellular myc gene in Burkitt's lymphoma].Postepy Hig Med Dosw. 1986 Jan-Feb;40(1):96-110. Postepy Hig Med Dosw. 1986. PMID: 3532072 Review. Polish. No abstract available.
Cited by
-
The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals.Mol Cell Biol. 2000 Jun;20(12):4309-19. doi: 10.1128/MCB.20.12.4309-4319.2000. Mol Cell Biol. 2000. PMID: 10825194 Free PMC article.
-
Oncogenic mutations in the FBXW7 gene of adult T-cell leukemia patients.Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):6731-6. doi: 10.1073/pnas.1601537113. Epub 2016 May 31. Proc Natl Acad Sci U S A. 2016. PMID: 27247421 Free PMC article.
-
Erroneous class switching and false VDJ recombination: molecular dissection of t(8;14)/MYC-IGH translocations in Burkitt-type lymphoblastic leukemia/B-cell lymphoma.Mol Oncol. 2013 Aug;7(4):850-8. doi: 10.1016/j.molonc.2013.04.006. Epub 2013 Apr 25. Mol Oncol. 2013. PMID: 23673335 Free PMC article.
-
Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: transrepression correlates with acceleration of apoptosis.Mol Cell Biol. 2000 Aug;20(16):6008-18. doi: 10.1128/MCB.20.16.6008-6018.2000. Mol Cell Biol. 2000. PMID: 10913183 Free PMC article.
-
Expression profiling of rectal tumors defines response to neoadjuvant treatment related genes.PLoS One. 2014 Nov 7;9(11):e112189. doi: 10.1371/journal.pone.0112189. eCollection 2014. PLoS One. 2014. PMID: 25380052 Free PMC article.
MeSH terms
Substances
Associated data
- Actions